Outlook: The Neuroscience Issue
Already one of the world’s premier institutions in neuroscience research, WashU Medicine is deepening its investment. Read about our approach, areas of focus and latest advances in Outlook Winter 2023-24.
$8 million awarded to study root causes of brain cell death in fatal pediatric diseases (Links to an external site)
Team science approach leverages expertise of researchers from diverse fields
Noninvasive, ultrasound-based brain biopsy is feasible, safe in people (Links to an external site)
Sonobiopsies generate genetic, molecular data to inform treatment decisions for brain diseases
How do toxic proteins accumulate in Alzheimer’s and other diseases? (Links to an external site)
Key steps leading to such accumulation identified; could inform new therapeutic approaches
Comprehensive Head & Neck Tumor Center established at Siteman Cancer Center (Links to an external site)
Washington University physicians provide multispecialty, cutting-edge, expert care to patients while advancing the field through innovative research
How do developing brains assemble and organize themselves? (Links to an external site)
Brain areas marked by distinct activity patterns very early, marsupial study shows
What to know about the new Alzheimer’s drug Leqembi (Links to an external site)
Washington University involved in clinical trials, will offer drug in collaboration with BJC HealthCare
Siteman earns prestigious merit extension from National Cancer Institute (Links to an external site)
Recognizes excellence in cancer care, prevention, research, training, outreach
Podcast: Newly approved drug may slow progression of Alzheimer’s (Links to an external site)
This episode of ‘Show Me the Science’ focuses on approval of a drug that attacks a key protein that contributes to dementia from Alzheimer’s disease
Cognitive function in Down syndrome-associated Alzheimer’s focus of grant (Links to an external site)
NIH-supported study lays groundwork for Alzheimer’s clinical trials involving people with intellectual disabilities
Study defines disparities in memory care (Links to an external site)
Provides baseline to measure progress toward racial equity in care for Alzheimer’s disease